tiprankstipranks
Trending News
More News >
Lytix Biopharma AS (DE:6BG)
:6BG
Germany Market
Advertisement

Lytix Biopharma AS (6BG) Income Statement

Compare
1 Followers

Lytix Biopharma AS Income Statement

Last quarter (Q2 2025), Lytix Biopharma AS's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q2, Lytix Biopharma AS's net income was kr-5.05M. See Lytix Biopharma AS’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 11.13Mkr 3.99Mkr 11.03Mkr 19.31Mkr 3.00K
Gross Profit
kr -23.46Mkr 3.99Mkr 11.03Mkr 19.31Mkr 3.00K
Operating Expenses
kr 77.17Mkr 100.78Mkr 76.70Mkr 67.29Mkr 42.38M
Depreciation and Amortization
kr 915.00Kkr 962.00Kkr 919.00Kkr 453.00Kkr 0.00
EBITDA
kr -93.22Mkr -86.88Mkr -54.91Mkr -47.56Mkr -42.09M
Operating Income
kr -95.90Mkr -96.78Mkr -65.67Mkr -47.98Mkr -42.37M
Other Income/Expenses
kr 6.37Mkr 8.89Mkr 9.60Mkr -94.00Kkr 284.00K
Pretax Income
kr -94.27Mkr -87.90Mkr -56.07Mkr -48.08Mkr -42.09M
Net Income
kr -94.27Mkr -87.90Mkr -56.07Mkr -48.08Mkr -42.09M
Per Share Metrics
Basic EPS
kr -1.74kr -2.19kr -1.41kr -1.45kr -1.09
Diluted EPS
kr -1.74kr -2.19kr -1.41kr -1.45kr -1.09
Weighted Average Shares Outstanding
54.13M 40.07M 39.67M 38.74M 38.74M
Weighted Average Shares Outstanding (Diluted)
54.13M 40.07M 39.67M 38.74M 38.74M
Currency in NOK

Lytix Biopharma AS Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis